We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Thoracic Tumors With 18F-FMT and 18F-FDG PET-CT A Clinicopathological Study

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00698373
First Posted: June 17, 2008
Last Update Posted: June 17, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
J~pharma
Information provided by:
Gunma University
  Purpose
L-[3-18F]-α-methyltyrosine (18F-FMT) is an amino-acid tracer for positron emission tomography (PET). The aim of this study was to determine whether PET-CT with 18F-FMT provides additional information for the preoperative diagnostic workup as compared with 18F-FDG PET. Tumor uptake of 18F-FMT was compared with several immunohistochemical markers including L-type amino acid transporter 1 (LAT1).

Condition
Non-Small Cell Lung Cancer

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Evaluation of Thoracic Tumors With 18F-FMT and 8F-FDG PET-CT: A Clinicopathological Study

Resource links provided by NLM:


Further study details as provided by Gunma University:

Groups/Cohorts
1
PET study

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with indeterminate pulmonary nodule suspicious of lung cancer were eligible for this prospective study.
Criteria

Inclusion Criteria:

  • Patients with indeterminate pulmonary nodule suspicious of lung cancer

Exclusion Criteria:

  • Patients with other malignancies and those who had received cancer treatment within the past 5 years were excluded.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

ClinicalTrials.gov Identifier: NCT00698373     History of Changes
Other Study ID Numbers: Molecular FMT imaging
First Submitted: June 12, 2008
First Posted: June 17, 2008
Last Update Posted: June 17, 2008
Last Verified: June 2008

Keywords provided by Gunma University:
Fluorine-18-α-methyltyrosine,
Positron emission tomography,
Fluorine-18-fluorodeoxyglucose,
Lung cancer,

Additional relevant MeSH terms:
Carcinoma, Non-Small-Cell Lung
Thoracic Neoplasms
Carcinoma, Bronchogenic
Bronchial Neoplasms
Lung Neoplasms
Respiratory Tract Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases